Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 715Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Interventions

Dexmedetomidine 2Saline Solution 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Dexmedetomidine × Clear all
NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed
40 enrolled

Dexmedetomidine

NCT04771637 2021-11-30

Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection

Yangzhou University

Phase NA Completed
140 enrolled

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡